OUP-backed utility customer data provider Urjanet has added $14.7m to its coffers.

MemorialCare Innovation Fund contributed to a series D round that brought the Caltech spinout's overall funding to more than $36m.

Kaiser Permanente contributed to a round that pushed the total raised by the Stanford-aligned cellular cancer therapy developer to $300m.

GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, an MIT spinout that has now raised at least $166m to date.

Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

The radiotherapy developer, which is exploiting UChicago research, has now raised $264m in funding overall.

Graphcore, which traces its origins back to University of Bristol, has added $150m to a round that already included Ahren Innovation Capital.

Oak Ridge spinout Verana Health has completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.

Medipal and Sony Innovation Fund by IGV were among the investors that boosted the liver disease drug spinout's latest round to $52.6m.

CU Boulder spinout Inscripta has now accumulated more than $259m from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.